**Core Concept:** Inhibition is a phenomenon in biochemistry where the activity of an enzyme is reduced by the binding of a molecule called an inhibitor. This can be competitive, non-competitive, or uncompetitive inhibition based on the type of binding to the enzyme. Increase in Km indicates that the inhibitor binds to the enzyme and alters its affinity for the substrate. Vmax remains the same because the number of enzymes and the rate-limiting steps are not affected by the inhibitor, as long as they are not involved in the inhibition process.

**Why the Correct Answer is Right:** In this case, the correct answer is:

**Correct Answer: C. Uncompetitive inhibition**

Uncompetitive inhibition occurs when the inhibitor binds to the enzyme-substrate complex, rather than the enzyme itself. This type of inhibition increases the Km (substrate concentration required for half-maximal velocity) but leaves Vmax (maximum velocity) unchanged. Since the inhibitor only affects the enzyme's affinity for the substrate, the rate-limiting steps and the number of enzymes remain unaffected.

**Why Each Wrong Option is Incorrect:**

**Option A. Competitive inhibition:** In competitive inhibition, the inhibitor competes with the substrate for binding to the enzyme, decreasing the Km value. However, Vmax remains unaffected, as the number of enzymes and the rate-limiting steps are not influenced by the inhibitor.

**Option B. Non-competitive inhibition:** Non-competitive inhibition is similar to uncompetitive inhibition, but the inhibitor binds to the enzyme's active site, decreasing Vmax. This is incorrect because the question states that Vmax remains unchanged, indicating the inhibitor is binding to the enzyme-substrate complex, not the enzyme active site.

**Option D. Complete inhibition:** Complete inhibition refers to a situation where the inhibitor completely blocks the enzyme activity, resulting in a decrease in both Km and Vmax. In this question, Km increases but Vmax remains the same, so this type of inhibition is incorrect.

**Clinical Pearl:** A clinical example of uncompetitive inhibition can be seen in the case of drugs like acetaminophen (paracetamol) and salicylic acid. The former is a competitive inhibitor, while the latter is an uncompetitive inhibitor. Both drugs are used for pain relief and fever reduction, but acetaminophen is more effective at higher substrate concentrations and causes less inhibition of enzyme function. Salicylic acid, on the other hand, is less effective at lower substrate concentrations but causes more inhibition of enzyme function. This differential effect is due to the binding site of salicylic acid on the enzyme, which is different from that of acetaminophen.